AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
UnitedHealth
UNH
|
$419M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$345M |
| 3 |
Meta Platforms (Facebook)
META
|
$329M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$326M |
| 5 |
Microsoft
MSFT
|
$320M |
Top Sells
| 1 |
Apple
AAPL
|
$264M |
| 2 |
Medtronic
MDT
|
$255M |
| 3 |
T-Mobile US
TMUS
|
$221M |
| 4 |
CELG
Celgene Corp
CELG
|
$198M |
| 5 |
Xerox
XRX
|
$185M |
Sector Composition
| 1 | Technology | 16.93% |
| 2 | Financials | 15.62% |
| 3 | Healthcare | 14.76% |
| 4 | Consumer Discretionary | 11.29% |
| 5 | Industrials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EIDX
2526
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $591K | ﹤0.01% |
19,000
+6,700
| +54% | +$208K |
|
|
DCPH
2527
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $589K | ﹤0.01% |
26,100
-496,781
| -95% | -$11.2M |
|
2528
ADT
ADT
$7.13B
| $586K | ﹤0.01% |
95,683
+29,950
| +46% | +$183K |
|
2529
1-800-Flowers.com
FLWS
$324M
| $585K | ﹤0.01% |
31,000
+1,100
| +4% | +$20.8K |
|
2530
Dime Community Bancshares
DCOM
$1.34B
| $583K | ﹤0.01% |
19,781
+300
| +2% | +$8.84K |
|
2531
Viking Therapeutics
VKTX
$3.03B
| $583K | ﹤0.01% |
70,300
| – | – |
|
2532
Forrester Research
FORR
$187M
| $578K | ﹤0.01% |
12,300
+4,200
| +52% | +$197K |
|
|
WAIR
2533
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $578K | ﹤0.01% |
52,100
+8,300
| +19% | +$92.1K |
|
|
ORC
2534
Orchid Island Capital
ORC
$958M
| $575K | ﹤0.01% |
18,080
+2,575
| +17% | +$81.9K |
|
2535
Quanterix
QTRX
$211M
| $574K | ﹤0.01% |
17,000
+5,200
| +44% | +$176K |
|
|
ACHN
2536
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $574K | ﹤0.01% |
214,100
+17,200
| +9% | +$46.1K |
|
2537
Catalyst Pharmaceutical
CPRX
$2.48B
| $571K | ﹤0.01% |
148,800
+59,700
| +67% | +$229K |
|
2538
Heritage Commerce
HTBK
$628M
| $570K | ﹤0.01% |
46,529
-200,982
| -81% | -$2.46M |
|
2539
Wave Life Sciences
WVE
$1.32B
| $569K | ﹤0.01% |
21,800
| – | – |
|
|
BGG
2540
DELISTED
Briggs & Stratton Corp.
BGG
| $566K | ﹤0.01% |
55,265
+10,114
| +22% | +$104K |
|
|
HUD
2541
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $565K | ﹤0.01% |
41,000
-2,200
| -5% | -$30.3K |
|
2542
Vishay Precision Group
VPG
$394M
| $553K | ﹤0.01% |
13,600
+600
| +5% | +$24.4K |
|
2543
Domo
DOMO
$603M
| $552K | ﹤0.01% |
20,200
-188,200
| -90% | -$5.14M |
|
2544
Peoples Bancorp
PEBO
$1.1B
| $552K | ﹤0.01% |
17,120
+270
| +2% | +$8.71K |
|
2545
Ethan Allen Interiors
ETD
$772M
| $551K | ﹤0.01% |
26,154
+12,800
| +96% | +$270K |
|
|
CCXI
2546
DELISTED
ChemoCentryx, Inc.
CCXI
| $551K | ﹤0.01% |
59,300
+12,800
| +28% | +$119K |
|
2547
MarineMax
HZO
$568M
| $549K | ﹤0.01% |
33,400
+11,900
| +55% | +$196K |
|
|
FSB
2548
DELISTED
Franklin Financial Network, Inc.
FSB
| $549K | ﹤0.01% |
19,700
+6,200
| +46% | +$173K |
|
|
ORBC
2549
DELISTED
ORBCOMM, Inc.
ORBC
| $549K | ﹤0.01% |
75,700
+6,700
| +10% | +$48.6K |
|
2550
Argan
AGX
$2.92B
| $548K | ﹤0.01% |
13,500
| – | – |
|